Different ways of thinking – Criticality and dual disorders

spectators in a lecture about a dual disorder.

Why is substance use more prevalent in people with mental health issues and is there a connecting neurobiological basis? Themes touched upon in an APA symposium on dual disorders, which included a presentation suggesting we may need news of thinking about the mechanisms at play in patients with co-occurrent mental disorder and substance use disorder.

Two conditions or one? This was the question posed by Dr Ruben Baler of the Science Policy Branch of the National Institute on Drug Abuse (NIDA) during an APA symposium on dual disorders. Mental illness and substance abuse commonly occur together and the co-occurrence of these two diagnoses has been termed ‘dual disorders’.

According to Dr Baler, progress in defining and describing dual disorders has been slow, in part because of our standard ways of thinking about the neurobiology of mental disorders and substance abuse.

Dr Baler opined that perhaps there is a need to think of dual disorders less as two conditions together, and, more broadly, to consider if our focus on neuronal structures and neurochemistry is actually insufficient to understand and explain the neural dynamics at play in dual disorders.

Always ready to change

He said that the linear thinking that addictive behaviour arises from a deficiency in dopamine reward centres and can be restored by correcting those deficiencies is too simplistic, reminding the audience of the myriad of feedback loops, controls and interconnections that add to the unpredictability of brain responses.

Concept of criticality

He suggested that there needs to be more research, for complex conditions like dual disorders, founded on concepts of ‘criticality’ – the ability of systems (in this case brain neural connectivity and networks) to function and operate in a manner which allows for abrupt adaptation and change.

Dr Baler said that this concept is based on the idea that the healthy brain operates and likes a loose synchronicity, where there neural activity can fluctuate, and switch rapidly, from its normal state to a more focussed – more quiescent– state for concentration and focus – or move in the other direction, just a rapidly, to a more excited and excitable state.

He suggested that oscillating alterations  and aberrations to this normal criticality might be at the core of many brain disorders – psychiatric and neurological.

For example, he said that this concept might go some way to explaining why, for example, deep brain stimulation can be an effective treatment in Parkinson’s disease, and may even explain why mindfulness can effect changes in mood and behaviour.

Bow-tie architecture

Dr Baler also reminded delegates of another concept that could be borne in mind when trying to understand what goes wrong in situations such as dual disorder – the fact that many brain systems work with a ‘bow-tie’ architecture. He explained that often there is a core component or unit that is a highly efficient, yet rigid and often fragile, bottleneck (# think of the knot in the bow tie #) to information flowing in, and information flowing out, and through, neural connections. Dr Baler said that in mental disorders and in substance abuse, there may be common or shared changes in the bow-tie functioning.

His presentation gave food for thought on how new ways of thinking about brain function and neural connectivity might spawn new approaches to researching the links leading to dual disorders.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Le informazioni contenute nel nuovo sito prescelto possono non essere conformi al D.Ivo 219/06 che regola la pubblicità dei medicinali per uso umano e le opinioni espresse non riflettono necessariamente le posizioni dell’azienda, non sono da essa avvallate.
Accesso riservato a Operatori Sanitari
Per accedere si prega di registrarsi o, in caso sia già stato fatto, di autenticarsi
L’accesso a Progress in Mind Italia è consentito unicamente agli Operatori Sanitari (medici e farmacisti). I contenuti di questo sito sono prodotti da un team di Operatori Sanitari il cui obiettivo è presentare le ultime novità in ambito psichiatrico e neurologico, attraverso interviste, registrazioni audio/video di seminari con opinion leader, report e sintesi di congressi sia internazionali che nazionali. Per poter accedere al sito è quindi necessario registrarsi e fornire alcuni dati così da poter verificare che l‘utente sia un Operatore Sanitario.
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country